Flavonoids in human health: From structure to biological activity

Current Nutrition and Food Science

Volumn 5, Issue 4, 2009, Pages 225-237

  Atmani, Djebbar ^a   Chaher, Nassima ^a   Atmani, Dina ^a   Berboucha, Meriem ^a   Debbache, Nadjet ^a   Boudaoud, Hania ^a  

^a UNIVERSITY OF BEJAIA   (Algeria)

Author keywords

Anti cancer; Antioxidant; Cardioprotective; Flavonoids; Lipid peroxidation

Indexed keywords

ALLOPURINOL; APIGENIN; APOLIPOPROTEIN E; BAICALEIN; CATECHIN; CHOLESTEROL; CHRYSIN; EPICATECHIN; EPIGALLOCATECHIN; FISETIN; FLAVANONE DERIVATIVE; FLAVONOID; FREE RADICAL; GALANGIN; KAEMPFEROL; LUTEOLIN; MANGANESE SUPEROXIDE DISMUTASE; MORIN; MYRICETIN; NARINGENIN; PROTEIN KINASE C; QUERCETIN; SCAVENGER; TAXIFOLIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROTECTION; CHEMICAL BOND; CHOLESTEROL BLOOD LEVEL; CRANBERRY JUICE; DIABETES MELLITUS; DIETARY INTAKE; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; FRUIT JUICE; HEALTH PROMOTION; HEART PROTECTION; HUMAN; LIPID PEROXIDATION; LIVER DISEASE; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RED WINE; REVIEW; STRUCTURE ACTIVITY RELATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 74749109440     PISSN: 15734013     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340109790218049     Document Type: Review

References (148)

1. Servais S. Altération mitochondriale et stress oxydant pulmonaire en réponse à l'ozone: Effet de l'âge et d'une supplémentation en Omega-3. Thèse de doctorate: Uuniversité Claude Bernard- Lyon1 2004; pp. 12-4.
2. Aron PM, Kennedy JA. Flavan-3-ols: nature, occurrence and biological activity. Mol Nutr Food Res 2008; 52: 79-104.
3. Brunet A. Signal transduction from membrane to the nucleus: variation on common themes. Bull Cancer 1998; 85(6): 527-37.
4. Koechlin-Ramonatxo C. Oxygen, oxidative stress and antioxidant supplementation, or another way for nutrition in respiratory diseases. Nutr Clin Métab 2006; 20(4): 165-77.
5. Januel C, Fay LB, Ruggiero D, Lagarde M, Vericel E. Covalent coupling of reduced glutathione with ribose: loss of co-substrate ability to glutathione peroxidase. Biochem Biophys Acta 2003; 1620(1): 125-32.
6. Deby-Dupont G, Deby C, Lamy M. Données actuelles sur la toxicité de l'oxygène: Current data on the toxicity of oxygen. Réanimation 2002; 11(1): 28-39.
7. 2 production. Free Rad Biol Med 2005; 39: 1249-61.
8. Pincemail J, Bonjean K, Cayeux K, Defraigne J-O. Physiological action of antioxidant defences. Nutr Clin Métab 2002; 16(4): 233-39.
9. Fiorucci S. Activités biologiques de composés de la famille des flavonoides : Approches par des méthodes de chimie quantique et de dynamique moléculaire. Thèse de Doctorat: Université de Nice-Sophia Antipolis 2006.
10. Durand G, Polidori A, Salles J-P, Pucci B. Synthesis of a new family of glycolipidic nitrones as potential antioxidant drugs for neurodegenerative disorders. Bioorg Med Chem 2003; 13(5): 859-62.
11. Favier M. Le stress oxydant, intérêt conceptuel et expérimental dans la compréhension des mécanismes des maladies et potentiel thérapeutique. L'Actualité Chimique 2003; pp. 108-15.
12. Cook NC, Samman S. Flavonoids -Chemistry, metabolism, cardioprotective effects and dietary sources. J Nutr Biochem 1996; 7: 66-76.
13. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease. An overview. Methods Enzymol 1990; 186: 1-85.
14. Nistico G, Cirilol HR, Fiskin K, Iannone M, Martino A, Rotilio G. NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Rad Biol Med 1992; 12: 177-81.
15. Carney JM, Strake-Reed PE, Oliver CN, et al. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity and loss in temporal and spatial memory by chronic administration of the spin trapping compound N-tert-buty-alfapheynitrone. PNAS 1991; 88: 3633-6.
16. Perry NSL, Houghton PJ, Sampson J, et al. In vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. J Pharm Pharmacol 2001; 53: 1347-56.
17. Frôhlich L, Riederer P. Free radical mechanisms in dementia of Alzheimer's type and the potential for anti-oxidant treatment. Drug Res 1995; 45: 443-6.
18. Wolff SP. Diabetes mellitus and free radicals. Br Med Bull 1993; 49: 642-52.
19. Hertog M, Feskens E, Hollman P, Katan M, Kromhout D. Dietary antioxidant: Flavonoids and risk of coronary heart disease. The zutphen elderly study. Lancet 1993; 342(8878): 1007-11.
20. Martin S, Andriambeloson E, Takeda K, Andriantsitohaina R. Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. Br J Pharmacol 2002; 135: 1579-87.
21. Ribereau-Gayon P. Notions générales sur les composés phénoliques. Les composés phénoliques des végétaux. Editions Dunod 1968; pp. 1-27.
22. Richter G. Les composés phénoliques métabolisme des végétaux (physiologie et biochimie). Editions Dunod 1993; pp. 331-9.
23. Bruneton J. Composés: shikimate-acétate. Pharmacognosie Phytochimie, Plantes médicinales Technique et documentation. Lavoisier 1993; 3: 199-383.
24. Pietta P. Flavonoids as antioxidants. J Nat Prod 2000; 63: 1035-42.
25. Lee H, Wang HW, Su HY, Hao NJ. The structure-activity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4: 5-f]quinoline. Mutagenesis 1994; 9(2): 101-06.
26. Dragsted L, Strube M, Leth T. Dietary levels of plant phenols and other non-nutritive components: could they prevent cancer? Eur J Cancer Prevent 1997; 6(6): 522-28.
27. Skerget M, Kotnik P, Hadolin M, RiznerHras A, Simonic M, Knez Z. Phenols, proanthocyanidins, flavones and flavonols in some plant materials and their antioxidant activities. Food Chem 2005; 89: 191-98.
28. De Rijke E, Out P, Niessen WMA, Ariese F, Gooijer C, Brinkman UAT. Analytical separation and detection methods for flavonoids. J Chromat A 2006; 1112: 31- 63.
29. Kahkonen MP, Hopia AI, Vuorela HJ, et al. Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem 1999; 47: 3954-62.
30. Hinneburg I, Damien Dorman HJ, Hiltunen R. Antioxidant activities of extracts from selected culinary herbs and spices. Food Chem 2006; 97: 122-29.
31. Silva EM, Souza JNS, Rogez H, Rees JF, Larondelle Y. Antioxidant activities and polyphenolic contents of fifteen selected plant species from the Amazonian region. Food Chem 2007; 101(3): 1012-18.
32. Djeridane A, Yousfi M, Nadjemi B, Boutassouna D, Stocker P, Vidal N. Antioxidant activity of some Algerian medicinal plant extracts containing phenolic compounds. Food Chem 2006; 97: 654-60.
33. Maisuthiaskul P, Suttajit M, Pongsawatmanit R. Assessment of phenolic content and free radical-scavenging capacity of some Thai indigenous plants. Food Chem 2007; 100: 1409-18.
34. Marwah RG, Fatope MO, Al Mahrooqi R, Varma GB, Al Abadi H, Al-Burtamani S-KS. Antioxidant capacity of some edible and wound healing plants in Oman. Food Chem 2007; 101: 465-70.
35. Atmani D, Chaher N, Ayouni K, et al. Antioxidant potential and phenol content of selected Algerian medicinal plants. Food Chem 2009; 112: 303-09.
36. Tsimogiannis DI, Oreopoulou V. Free radical scavenging and antioxidant activity of 5, 7, 3', 4'-hydroxy-substituted flavonoids. Innovative Food Sci and Emerging Technol 2004; 5: 523-28.
37. Soobrattee MA, Veegheen VS, Luximon-Ramma A, Aruma OI, Bahorum T. Phenolics as potential antioxydant therapeutic agents: Mechanism and actions. Mutation Res 2005; 279: 200-13.
38. Rice Evans CA, Miller JN, Paganga G. Antioxidant properties of phenolic compounds. Trends Plant Sci Rev 1997; 2(4): 152-59.
39. Rusak G, Gutzeit HO, Muller JL. Structurally related flavonoids with antioxidative properties differentially affect cell cycle progression and apoptosis of human, acute leukaemia cells. Nutr Res 2005; 25: 141-53.
40. Tsimogiannis DI, Oreopoulou V. The contribution of flavonoid Cring on the DPPH free radical scavenging efficiency. A kinetic approach for the 3', 4'-hydroxy substitutes members. Innovative Food Sci Emerg Technol 2006; 7: 140-46.
41. Cai Y, Sun M, Xing J, Luo Q, Corke H. Structure-radical scavenging activity relationships of phenolic compounds from traditional Chinese medicinal plants. Life Sci 2006; 78: 2872-88.
42. Villaño D, Fernandez-Pachon MS, Moya ML, Troncoso AM, Garci-Parilla MC. Radical scavenging ability of poliphenolic compounds towards DPPH free radical. Talanta 2006; 71: 230-35.
43. Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 2002; 13(10): 572-84.
44. Hadi M. La quercetine et ses dérivés : molécules à caractère prooxydant ou capteurs de radicaux libres ; études et applications thérapeutiques. Thèse de Doctorat. Université Louis Pasteur. Domaine: Pharmacochimie 2004; p. 84.
45. Balasundram N, Sundram K, Samman S. Phenolic compounds in plants and agri-industrial by-products. Food Chem 2006; 99(1): 191-203.
46. Diaz MN, Frei B, Vita JA, Keaney JF. Heart Disease Antioxidants and Atherosclerotic. N Engl J Med 1997; 337(6): 408-16.
47. Tsimikas MDS, Witztum MDJL. Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. Am Heart Assoc 2001; 103: 1930-32.
48. Rankin SM, Leake DS. The modification of low density lipoproteins by macrophages by oxidation or proteolysis. Agents Actions Suppl 1988; 26: 233-39.
49. Kumar PS, Sucheta S, Deepa VS, Selavamani P, Latha S. Antioxidant activity in some selected Indian medicinal plants. African J Biotechnol 2008; 7(12): 1826-28.
50. Schaffer S, Schmitt-Schillig S, Muller WE, Ecker GP. Antioxidant properties of Mediterranean food plant extracts: geographical differences. J Physiol Pharmacol Suppl 2005; 1: 115-24.
51. Desmarchelier C, Mongelli E, Coussio J, Ciccia G. Inhibition of lipid peroxidation and iron (II)-dependant DNA damage by extracts of Pothomorphe peltata (L.) Miq. Braz J Med Biol Res 1997; 30: 85-91.
52. Ruel G, Pomerleau S, Couture P, Lamarche B, Couillard C. Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption. Metabolism 2005; 54(7): 856-61.
53. Fanconi F, Coinu R, Carta S, et al. Antioxidant effect of two virgin oils depends on the concentration and composition of two minor compounds. J Agric Food Chem 2006; 54: 3121-25.
54. Cao W, Myers-Powell BA, Braciale TJ. Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes. J Exp Med 1994; 179(1): 195-202.
55. Cherubini A, Beal M, Frei B. Black tea increases the resistance of human plasma to lipid peroxidation in vitro, but not ex vivo. Free Rad Biol Med 1999; 27: 381-87.
56. McAnlis G, McEneny E, Pearce J, Young I. Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur J Clin Nutr 1998; 52: 202-06.
57. Mckay DL, Blumberg JF. The role of tea in human health. J Am Coll Nutr 2002; 21(1): 1-13.
58. Manach C, Scalbert A, Morand C, Rémésy, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79(5): 727-47.
59. Van het hof KH, Wiseman SA, Yang Chung S, Tijburg LBM. Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc Soc Exp Biol Med 2003; 220(4): 203-9.
60. Gibson S. Iron intake and iron-status of preschool children: associations with breakfast cereals, vitamin C and meat. Public Health Nutr 1999; 2: 521-28.
61. Hurrell RF, Reddy M, Cook JD. Inhibition of non-haem iron absorption in man by polyphenolic containing beverages. Brit J Nutr 1999; 81: 289-95.
62. Auger C, Laurent N, Laurent C, et al. Hydroxycinnamic acids do not prevent aortic atherosclerosis in hypercholesterolemic golden Syrian hamsters. Hydroxycinnamic acids do not prevent aortic atherosclerosis in hypercholesterolemic golden Syrian hamsters. Life Sci 2004; 74(19): 2365-77.
63. Bentzon JF, Skovenborg E, Hansen C, et al. Red wine does not reduce mature atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001; 103: 1681-87.
64. Zern TL, West KL, Fernandez ML. Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. Am Soc Nutr Sci 2003; 133: 2268-72.
65. Yokozawa T, Dong E, Zhong Liu WL, Shimizu M. Antioxidative activity of flavones and flavonones in vitro. Phytotherapy Res 1997; 11: 446-49.
66. Wedworth SM, Lynch S. Dietary flavonoids in atherosclerosis prevention. Ann Pharmacother 1995; 29(6): 627-28.
67. Reed J. Cranberry flavonoids atherosclerosis and cardiovascular health. Crit Rev Food Sci Nutr 2002; 42(3 Suppl): 301-16.
68. Kostyuk VA, Potapovich AI, Strigunova EN, Kostyuk, Afanas'evb IB. Experimental evidence that flavonoid metal complexes may act as mimics of superoxide dismutase. Arch Biochem Biophys 2004; 428: 204-08.
69. Ratty AK, Das NP. Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationship. Biochem Med Metab Biol 1988; 39(1): 69-79.
70. Cao G, Sofic E, Prior R. Antioxidant and prooxidant behaviour of flavonoids: structure-activity relationships. Free Rad Biol Med 1997; 22: 749-60.
71. Cholbi MR, Paya M, Alcaraz MJ. Inhibitory effects of phenolic compounds on CCl4-induced microsomal lipid peroxidation. Experientia 1991; 47(2): 195-9.
72. Adaramoye OA, Farombi EO, Adeyemi EO, Emerole GO. Comparative study on the antioxidant properties of flavonoids of Garcinia kola seeds. J Med Sci 2005; 21(3): 331-39.
73. Van Acker SABE, Van Den B, Dirk-jan Tromp MNJL, et al. Structural aspects of antioxidant activity of flavonoids. Free Rad Biol Med 1996; 20(3): 331-42.
74. Afanas'eva IB, Ostrakhovitch EA, Mikhal'chik EV, Ibragimova GA, Korkina LG. Enhancement of antioxidant and anti-inflammatory activities of bioflavonoid rutin by complexation with transition metals. Biochem Pharmacol 2001; 61(6): 677-84.
75. Oboh G. Effect of bleaching on the antioxidant properties of some tropical green leafy vegetables. LWT 2005; 38 (5): 513-17.
76. Kaneko T, Kaji K, Matsuo M. Protection of linoleic acid hydropeoxide induced cytoxicity by phenolic antioxidants. Free Rad Biol Med 1994; 16: 405-09.
77. Spasojevic I, Maksimovic V, Bqsic G. 5-Fluorouracil effects on erythrocytes in relation to its cardiotoxicity. Membrane structure and functioning. J Chem Inform Model 2005; 25: 1680-85.
78. Zizkovic J, Mujic I, Zizkovic Z, Vidovic S, Mujic A. Capacity of extracts of sweet chestnut concerning to remove lipid peroxidation. Central Eur J Agric 2008; 9 (2): 353-62.
79. Silva CG, Herdeiro RS, Mathias CJ, et al. Evaluation of antioxidant activity of Brazilian plants. Pharmacol Res 2005; 52: 229-33.
80. Arora A, Byrem T, Nair M, Strasburg G. Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids. Arch Biochem Biophys 2000; 373(1): 102-09.
81. Viana MM, Barbas C, Bonet B, et al. In vitro effects of a flavonoid rich extract on LDL oxidation. Atherosclerosis 1996; 123: 83-91.
82. Noro T, Oda Y, Miyase T, Ueno A, Fukushima S. Inhibitors of xanthine oxidase from the flowers and buds of Daphne genkwa. Chem Pharmaceut Bull 1983; 31(11): 3984-87.
83. Hatano T, Yasuhara T, Fukuda T, Noro T, OkudaT. Phenolic constituents of licorice. II: Structures of licopyranocoumarin, licoarylcoumarin and glisoflavone, and inhibitory effects of licorice phenolics on xanthine oxidase. Chem Pharmaceut Bull 1989; 37(11): 3005-09.
84. Chang TMS. Preparation and characterisation of xanthine oxidase immobilised by microencapsulation in artificial cells for the removal of hypoxanthine. Biomater Artif Cells Artif Organs 1989; 17(5): 611-16.
85. Laughton MJ, Evans PJ, Moroney MA, Hoult JR, Halliwell B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem Pharmacol 1991; 42(9): 1673-81.
86. Sies H. Strategies of antioxidant defense. Eur J Biochem 1993; 215: 213-19.
87. Kong LD, Cai Y, Huang WW, Chang CHK, Tan RX. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharmacol 2000; 73: 199-207.
88. Umamaheshwari M, Kumar AK, Somasundaram A, Sivashanmugam T, Subhadrdevi V, Ravi TK. Xanthine oxidase inhibitory activity of some Indian medicinal plants. J Ethnopharmacol 2007; 109: 547-51.
89. Cos P, Ying L, Calomme M, et al. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod 1998; 61: 71-76.
90. Nagao A, Seki M, Kobayashi H. Inhibition of xanthine oxidase by flavonoids. Biosc Biotech Biochem 1999; 63(10): 1787-90.
91. Van Hoorn DEC, Nijveldt RJ, Van Leeuwen, et al. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Pharmacol 2002; 451: 111-18.
92. Stefanovic-Racic M, Stadler J, Evans CH. Nitric oxide and arthritis. Arth Rheum 1993; 36(8): 1036-43.
93. Sies H, Schewe T, Heiss C, Kelm M. Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr 2005; 81(1): 304S-312S.
94. Chan MM-Y, Mattiacci JA, Hwang HS, Shah A, Fong D. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem Pharmacol 2000; 60(10): 1539-48.
95. Kim H, Kim YS, Sun Kim Y, Suk K. The plant flavonoid wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production. Neurosci Lett 2001; 309(1): 67-71.
96. Luo L, Sun Q, Mao YY, Lu YH, Tan RX. Inhibitory effects of flavonoids from Hypericum perforatum on nitric oxide synthase. J Ethnopharmacol 2004; 93(2-3): 221-25.
97. Rassaf T, Kelm M. Cocoa flavanols and the nitric oxide-pathway: targeting endothelial dysfunction by dietary intervention. Drug Discov Today: Dis Mech 2008; 5(3-4): e273-78.
98. Soliman KF, Mazzio EA. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc Soc Exp Biol Med 1998; 218: 390-97.
99. Kim HK, Cheon BS, Kim YH, Kim SY, Kim HP. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their strucrure-activity relationships. Biochem Pharmacol 1999; 58(5): 579-765.
100. Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 2001; 68(8), 921-31.
101. Matsuda H, Morikawa T, Ando S, Toguchida I, Yoshikawa M. Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action. Bioorg Med Chem 2003; 11(9): 1995-2000.
102. Harrison JE, Schultz J. Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 1976; 251: 1371-74.
103. Arnljots K, Olsson I. Myeloperoxidase precursors incorporate heme. J Biol Chem 1987; 262(22): 10430-33.
104. Van Dalen CJ, Winterbourn CC, Senthilmohan R, Kettle AJ. Nitrite as a Substrate and Inhibitor of Myeloperoxidase implications for nitration and hypochlorous acid production at sites of inflammation. Biol Chem 2000; 275(16): 38-11644.
105. Savenkova ML, Mueller DM, Heinecke JW. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem 1994; (269): 20394-400.
106. 2/ cl-mediated modification of low density lipoprotein. J Biol Chem 2001; 276: 1822-28.
107. Schewe T, Sies H. Myeloperoxidase-induced lipid peroxidation of LDL in the presence of nitrite. Protection by cocoa flavanols. Bio Factors 2005; 24(1-4): 49-58.
108. Gonzalez D, Drapier J-C, Bouton C. Endogenous nitration of iron regulatory protein-1 (irp-1) in nitric oxide-producing murine macrophages. Further insight into the mechanism of nitration in vivo and its impact on IRP-1 function. J Biol Chem 2004; 279(41): 43345-51.
109. Pincemail J, Deby C, Thirion A, de Bruyn-Dister M, Goutier R. Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds. Cell Mol Life Sci (CMLS) 1988; 44(5): 450-53.
110. Kostyuk VA, Kraemer T, Sies H, Schewe T. Myeloperoxidase/nitrite-mediated lipid peroxidation of low-density lipoprotein as modulated by flavonoids. FEBS Lett 2003; 537(1): 146-50.
111. Shiba Y, Kinoshita T, Chuman H, et al. Flavonoids as substrates and inhibitors of myeloperoxidase: Molecular actions of aglycone and metabolites. Chem Res Toxicol 2008; 21(8): 1600-09.
112. Neto CC. Cranberry and blueberry: Evidence for protective effects against cancer and vascular disease. Mol Nutr Food Res 2007; 51: 653-64.
113. 2+-induced oxidation. J Sci Food Agric 2001; 81: 1306-13.
114. Neto CC, Sweeney-Nixon ML, Lamoureaux TL, Solomon F. Cranberry phenolics: Effects on oxidase processes, neuron cell death and tumor cell growth. Phenolic compounds in foods and natural health products. Washington, DC: ACS Books 2005; pp. 271-82.
115. Youdim KA, McDonald J, Kalt W, Joseph JA. Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. J Nutr Biochem 2002; 13: 282-88.
116. Bomser J, Madhavi DL, Singletary K, Smith MA. In vitro anticancer activity of fruit extracts from Vaccinium species. Planta Med 1996; 62: 212-16.
117. Ferguson P, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr 2004; 134: 1529-35.
118. Yan X, Murphy BT, Hammond GB, Vinson JA, Neto CC. Antioxidant activities and anti-tumor screening of extracts from cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem 2002; 20: 5844-49.
119. Murphy BT, MacKinnon SL, Yan X, Neto CC. Identification of triterpene hydroxycinnamates with in vitro antitumor activity from whole cranberry fruit (Vaccinum macrocarpon). J Agric Food Chem 2003; 51: 3541-45.
120. 2 consumption, and tumor interstitial fluid pressure. Anticancer Res 2001; 21: 2827-33.
121. Es-Saady D, Simon A, Jayat-Vignoles C, Chulia AJ, Delage C. MCF-7 cell cycle arrest at G1 through ursolic acid and increased reduction of tetrazolium salts. Anti-cancer Res 1996; 16: 481-86.
122. Anderson GD, Rosito G, Mohustsy MA, Elmer GW. Drug interaction potential of soy extract and Panax ginseng. J Clin Pharmacol 2003; 43 (6): 643-8.
123. Novotny L, Vachalkova A, Biggs D. Ursolic acid: an antitumorigenic and chemopreventive activity: minireview. Neoplasma 2001; 48: 241-46.
124. Kim SY, Gao JJ, Kangh K. Two flavonoids from the leaves of Morus alba induce differentiation of the human promyelocytic leukemia (HL-60) cell line. Biol Pharmaceut Bull 2000; 23(4): 451-55.
125. Seeram NP, Adams LS, Hardy ML, Heber D. Total cranberry extract versus its phytochemical constituents: Anti-proliferative and synergistic effects against human tumor cell lines. J Agric Food Sci 2004; 52: 2512-17.
126. Ramos S, Alia M, Bravo L, Goya L. Comparative effects of food-derived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). J Agric Food Chem 2005; 53: 1271-80.
127. Richter M, Ebermann R, Marian B. Quercetin-induced apoptosis in colorectal tumor cells: Possible role of EGF receptor signaling. Nutr Cancer 1999; 34: 88-99.
128. Choi J, Kim J, Lee J, Kang C. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int J Oncol 2001; 19: 837-44.
129. Ranelletti FO, Maggiano N, Serra FG. Quercetin inhibits p-21 Ras expression in human colon cancer cell lines and in primary colorectal tumours. Int J Cancer 2000; 85: 438-45.
130. He X, Liu RH. Cranberry phytochemicals: Isolation, structure elucidation and their antiproliferative and antioxidant activities. J Agric Food Chem 2006; 54: 7069-74.
131. Atalay M, Gordillo G, Roy S, Rovin B. Anti-angiogenic property of edible berries in a model of hemangioma. FEBS Lett 2003; 544: 252-57.
132. Ferguson PJ, Kurowska EM, Freeman DJ, Chambers AF, Koropatnick DJ. In vivo inhibition of growth of human tumor cell lines by flavonoid fractions from cranberry extract. Nutr Cancer 2006; 56: 86-94.
133. Roy S, Khanna S, Alessio HM, Vider J. Anti-angiogenic property of edible berries. Free Radic Res 2002; 36: 1023-31.
134. Newton AC. Protein Kinase C: structure-function and regulation. minireview. J Biol Chem 1995; 270(48): 28495-98.
135. Agullo G, Gamet-Payrastre L, Manenti S, et al. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-Kinase: A comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997; 53(11): 1649-57.
136. Brownson DM, Azios NG, Fuqua Brie K, Dharmawardhane Su F, Mabry TJ. Flavonoid effects relevant to cancer. J Nutr 2002; 132(11): 3482S-89S.
137. Gamet-Payrastre L, Manenti S, Gratacap M-P, Tulliez J, Chap H, Payrastre B Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 1999; 32 (3): 279-86.
138. lck protein tyrosine Kinase inhibitory activity of flavonoid derivatives using MLR and GAPLS. Int J Mol Sci 2008; 9(9): 1876-92.
139. Ferriola PC, Cody V, Middleton E. Protein kinase C inhibition by plant flavonoids: Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 1989; 38(10): 1617-24.
140. Kantengwa S, Polla BS. Flavonoids, but not protein kinase C inhibitors, prevent stress protein synthesis during erythrophagocytosis. Biochem Biophys Res Comm 1991; 180(1): 308-14.
141. Jinsart W, Ternai B, Polya GM. Inhibition of rat liver cyclic AMP-dependent protein kinase by flavonoids. Biol Chem Hoppe-Seyler 1992; 373(4): 205-11.
142. Picq M, Dubois M, Munari-Silem Y, Prigent AF, Pacheco H. Flavonoid modulation of protein kinase C activation. Life Sci 1989; 44(21): 1563-71.
143. Manthey JA. Biological properties of flavonoids pertaining to inflammation. Microcirculation 2000; 7: S29-34.
144. Alexandrakis M, Singh L, Boucher W, Letourneau R, Theofilopoulos P, Theoharides TC. Differential effect of flavonoids on inhibition of secretion and accumulation of secretory granules in rat basophilic leukemia cells. Int J Immunopharmacol 1999; 21(6): 379-90.
145. st international conference on polyphenols and health. Bioavailability and bioefficacy of polyphenols in humans. Am J Clin Nutr 2005; 81(1): 243S-5S.
146. Hagiwara M, Inoue S, Tanaka T, Nunoki K, Ito M, Hidaka H. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases. Biochem Pharmacol 1988; 37(15): 2987-92.
147. Jinsart W, Ternai B, Polya GM. Inhibition of wheat embryo calcium-dependent protein kinase and avian myosin light chain kinase by flavonoids and related compounds. Biol Chem 1991; 372(9): 819-27.
148. Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol Rev 2000; 52: 673-751.